Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Mandigo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Double Trouble: Concomitant <i>RB1</i> and <i>BRCA2</i> Depletion Evokes Aggressive PhenotypesAmy C Mandigo, Karen E Knudsen
Environmental Geochemistry and Health|October 22, 2015
Chemical contamination of soils in the New York City area following Hurricane SandyAmy C Mandigo, Dana J DiScenza, Alison R Keimowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Relevance of pRB Loss in Human MalignanciesAmy C Mandigo, Scott A Tomlins, William K Kelly, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
Plos One|January 22, 2021
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progressionFabio Quaglia, Shiv Ram Krishn, Yanqing Wang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Double Trouble: Concomitant <i>RB1</i> and <i>BRCA2</i> Depletion Evokes Aggressive PhenotypesAmy C Mandigo, Karen E Knudsen
Environmental Geochemistry and Health|October 22, 2015
Chemical contamination of soils in the New York City area following Hurricane SandyAmy C Mandigo, Dana J DiScenza, Alison R Keimowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Relevance of pRB Loss in Human MalignanciesAmy C Mandigo, Scott A Tomlins, William K Kelly, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
Plos One|January 22, 2021
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progressionFabio Quaglia, Shiv Ram Krishn, Yanqing Wang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Pageof 2